Tag: National Policy Analysis #514

Spurring Lower Prices: FDA Aided America’s Rx Drug Consumers By Not Banning Authorized Generics

National Policy Analysis #514 /
For years, generic drug manufacturers have been telling us that making more generic drugs available - earlier - is the key to saving consumers money and bringing greater access to prescription drugs. Competition, they said, will benefit millions of Americans ...
READ MORE

The National Center for Public Policy Research is a communications and research foundation supportive of a strong national defense and dedicated to providing free market solutions to today’s public policy problems. We believe that the principles of a free market, individual liberty and personal responsibility provide the greatest hope for meeting the challenges facing America in the 21st century.